MyMD Pharmaceuticals, Inc. (MYMD)
NASDAQ: MYMD · IEX Real-Time Price · USD
2.500
0.00 (0.00%)
At close: Apr 19, 2024, 4:00 PM
2.490
-0.010 (-0.40%)
After-hours: Apr 19, 2024, 6:25 PM EDT

MyMD Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2011
Net Income
-8.22-15.2-29.89-9.49-3.89-10.85-7.37-3.3-9.31-3.14
Upgrade
Depreciation & Amortization
0000.020.070.230.250.290.30.35
Upgrade
Share-Based Compensation
2.910.3415.042.860.390.040.310.080.050.55
Upgrade
Other Operating Activities
-11.892.59-4.661.940.352.071.73-1.243.83-1.64
Upgrade
Operating Cash Flow
-12.98-12.27-19.52-4.66-3.07-8.5-5.08-4.17-5.13-3.88
Upgrade
Capital Expenditures
00000.01-0.07-0.05-0.12-0.11-0.02
Upgrade
Acquisitions
001.3800000-0.060
Upgrade
Change in Investments
1.856.9118.470-3.95-0.29-4.963.975.25-9.27
Upgrade
Other Investing Activities
--------0.010
Upgrade
Investing Cash Flow
1.856.9119.850-3.94-0.36-5.013.845.08-9.29
Upgrade
Share Issuance / Repurchase
05.551.191.986.971.955.80013.85
Upgrade
Debt Issued / Paid
00-1.122.700000-0.31
Upgrade
Other Financing Activities
13.07----7.164.66---0.02
Upgrade
Financing Cash Flow
13.075.550.074.686.979.1110.460013.52
Upgrade
Net Cash Flow
1.930.190.410.01-0.050.240.37-0.33-0.050.35
Upgrade
Free Cash Flow
-12.98-12.27-19.52-4.66-3.07-8.57-5.13-4.3-5.25-3.91
Upgrade
Free Cash Flow Margin
------514.56%-153.07%-145.11%-248.00%-88.29%
Upgrade
Free Cash Flow Per Share
-8.42-9.48-16.72-4.96-300.46-1056.01-6310.82-9114.77-11753.87-9488.77
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).